These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10667603)

  • 1. Heregulin regulation of autocrine motility factor expression in human tumor cells.
    Talukder AH; Adam L; Raz A; Kumar R
    Cancer Res; 2000 Jan; 60(2):474-80. PubMed ID: 10667603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heregulin induces expression, DNA binding activity, and transactivating functions of basic leucine zipper activating transcription factor 4.
    Talukder AH; Vadlamudi R; Mandal M; Kumar R
    Cancer Res; 2000 Jan; 60(2):276-81. PubMed ID: 10667576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional up-regulation of paxillin expression by heregulin in human breast cancer cells.
    Vadlamudi R; Adam L; Tseng B; Costa L; Kumar R
    Cancer Res; 1999 Jun; 59(12):2843-6. PubMed ID: 10383144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH; Lin CC; Lin JK; Chen WJ
    J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
    Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
    Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion.
    Mazumdar A; Adam L; Boyd D; Kumar R
    Cancer Res; 2001 Jan; 61(1):400-5. PubMed ID: 11196194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihuman epidermal growth factor receptor 2 antibody herceptin inhibits autocrine motility factor (AMF) expression and potentiates antitumor effects of AMF inhibitors.
    Talukder AH; Bagheri-Yarmand R; Williams RR; Ragoussis J; Kumar R; Raz A
    Clin Cancer Res; 2002 Oct; 8(10):3285-9. PubMed ID: 12374700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.
    Schaefer G; Fitzpatrick VD; Sliwkowski MX
    Oncogene; 1997 Sep; 15(12):1385-94. PubMed ID: 9333014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors.
    Barnes CJ; Li F; Mandal M; Yang Z; Sahin AA; Kumar R
    Cancer Res; 2002 Mar; 62(5):1251-5. PubMed ID: 11888885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor regulation of a 26S proteasomal subunit in breast cancer.
    Barnes CJ; Li F; Talukder AH; Kumar R
    Clin Cancer Res; 2005 Apr; 11(8):2868-74. PubMed ID: 15837734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
    Ram TG; Hosick HL; Ethier SP
    J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
    Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A
    Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction or suppression of expression of cytochrome C oxidase subunit II by heregulin beta 1 in human mammary epithelial cells is dependent on the levels of ErbB2 expression.
    Sun Y; Lin H; Zhu Y; Ma C; Ye J; Luo J
    J Cell Physiol; 2002 Aug; 192(2):225-33. PubMed ID: 12115729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three-dimensional and temporo-spatial model to study invasiveness of cancer cells by heregulin and prostaglandin E2.
    Adam L; Mazumdar A; Sharma T; Jones TR; Kumar R
    Cancer Res; 2001 Jan; 61(1):81-7. PubMed ID: 11196203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage.
    Menendez JA; Mehmi I; Lupu R
    Int J Oncol; 2005 Mar; 26(3):649-59. PubMed ID: 15703820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factor regulation of the molecular chaperone calnexin.
    Li F; Mandal M; Barnes CJ; Vadlamudi RK; Kumar R
    Biochem Biophys Res Commun; 2001 Dec; 289(3):725-32. PubMed ID: 11726208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
    Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
    J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression.
    Xu F; Yu Y; Le XF; Boyer C; Mills GB; Bast RC
    Clin Cancer Res; 1999 Nov; 5(11):3653-60. PubMed ID: 10589783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heregulin up-regulates heat shock protein-70 expression in breast cancer cells.
    Mandal M; Li F; Kumar R
    Anticancer Res; 2002; 22(4):1965-9. PubMed ID: 12174871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification.
    Ram TG; Schelling ME; Hosick HL
    Cell Growth Differ; 2000 Mar; 11(3):173-83. PubMed ID: 10768865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.